A McGill University-led study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

For the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility, according ...

Research that yields insights on dopamine "could also shed light on dopamine-related disorders such as Parkinson's disease, ...

Scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility. PET imaging shows that the brain increases dopamine production when completing cognitively demanding tasks ...

For the first time, researchers have directly observed dopamine release in the human brain during moments of cognitive flexibility.

Enrollment for the Phase II trial follows FDA clearance of SPG302 Investigational New Drug application for schizophrenia.

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

A 33-year-old woman hears brutal and frightening voices daily but continues her college studies. A middle-aged man, who served in the Navy and has since struggled with substance ...

Zebra finches learn their courtship songs early in life by first listening to their fathers and memorizing the melodies.

Washingtonians with schizophrenia are curious about a recently FDA-approved drug to treat their symptoms but much is unknown about how well it works.